Market revenue in 2023 | USD 26,054.8 million |
Market revenue in 2030 | USD 32,132.9 million |
Growth rate | 3% (CAGR from 2023 to 2030) |
Largest segment | Joint replacement/ orthopedic implants |
Fastest growing segment | Orthobiologics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Joint Replacement/ Orthopedic Implants, Trauma, Sports Medicine, Orthobiologics |
Key market players worldwide | Medtronic PLC, Stryker Corp, Zimmer Biomet Holdings Inc, DePuy Synthes, Smith & Nephew PLC, Aesculap, Conmed Corp, NuVasive, Enovis Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to orthopedic devices market will help companies and investors design strategic landscapes.
Joint replacement/ orthopedic implants was the largest segment with a revenue share of 41.74% in 2023. Horizon Databook has segmented the U.S. orthopedic devices market based on joint replacement/ orthopedic implants, trauma, sports medicine, orthobiologics covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. is one of the largest markets for orthopedic devices. Obesity is a result of an inactive lifestyle and poor eating practices. As of March 2020, the CDC predicted that 41.9% of U.S. citizens were obese. Many illnesses, including cardiovascular problems and rheumatoid arthritis, are caused by obesity.
Thus, a sedentary lifestyle and a high prevalence of diseases are among the key factors boosting the orthopedic devices market in the U.S. The U.S. performs more than 800,000 knee replacement surgeries each year, mostly because there are high-precision devices, painless procedures, and high-quality surgical supplies available.
Moreover, the market is expanding as a result of the presence of major market players who are pursuing expansion strategies like product launches, mergers, acquisitions, partnerships, and collaborations. For instance, in November 2022, Zimmer Biomet announced U.S. FDA approval for Persona OsseoTi Knee Tibia, intended for knee replacement without cement.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. orthopedic devices market , including forecasts for subscribers. This country databook contains high-level insights into U.S. orthopedic devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account